Acupuncture for irritable bowel syndrome – an exploratory randomised controlled trial

This exploratory study conducted in Birmingham, United Kingdom, investigated the efficacy of acupuncture as a treatment for irritable bowel syndrome (IBS), a chronic condition that markedly impairs patients' quality of life. The research was motivated by the need for effective alternatives in a condition where conventional treatments often have limitations. The investigators used a pragmatic randomized controlled trial design, comparing traditional acupuncture combined with usual medical care versus usual medical care alone. Thirty patients were recruited from four general practice databases; inclusion criteria were based on Rome II diagnostic criteria for IBS and a severity score greater than 100.

Participants were randomized 1:2, with 10 in the acupuncture group and 20 in the control group. Treatment consisted of up to 10 sessions of acupuncture over three months delivered by five acupuncturists registered with the British Acupuncture Council, each with at least five years of experience. The protocol allowed enough flexibility for individualized treatment while maintaining adequate standardization for replication. The acupuncturists used primarily Five Element style and Traditional Chinese Medicine, with frequently used points including ST-36, PC-6, LI-4, SP-6, SP-8, KI-3, CV-12, and LR-3.

The primary outcome was the IBS Symptom Severity Score (IBS-SSS) at three months, a validated scale ranging from 0 to 500 points. Results were striking, showing a statistically and clinically significant 138-point difference favoring acupuncture (95% CI, 66 to 210; P = 0.001). The acupuncture group's score fell from 343 to 128 points, while the control group declined only from 322 to 287 points. Beyond bowel symptoms, acupuncture also produced significant benefits in non-colonic IBS symptoms, an area where conventional medications are not effective.

Adherence was high; patients completed an average of 8 of 10 prescribed sessions. Seventy-five percent of patients in the acupuncture group were able to stop or reduce their medications, compared with 44% in the control group. Acceptability was excellent: eight of nine patients reported they would receive acupuncture again. With regard to safety, no serious adverse events were reported, only mild effects such as dizziness during treatment and transient symptom worsening in some cases.

The study also provided important data for planning a larger trial, calculating that 216 patients would be needed for a definitive study. Limitations include the small sample size, lack of blinding (inherent to the pragmatic design), and the inability to separate specific from placebo effects. However, the observed effect size was much larger than placebo effects reported in other IBS studies. The findings suggest acupuncture may provide a valuable alternative for patients with IBS, especially given the limitations of current pharmacologic treatments.

The pragmatic design, while not allowing distinction between specific and placebo effects, is appropriate for evaluating cost-effectiveness and informing decisions about service provision. This study represents an important first step in establishing the evidence base for acupuncture in the treatment of IBS in primary care.